Revium Rx (RVRC) Shares Outstanding (2024 - 2026)

Revium Rx has disclosed Shares Outstanding (Entity) across 3 years of filings, most recently posting $60.7 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) changed 0.0% year-over-year to $60.7 million; the TTM figure through Jun 2026 stood at $60.7 million (changed 0.0% YoY), while the FY2025 annual figure was $60.7 million, changed 0.0% from the prior year.
• Shares Outstanding (Entity) came in at $60.7 million for Q2 2026 at Revium Rx, roughly flat from $60.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $60.7 million in Q4 2024 to a low of $60.7 million in Q4 2024.
• Average Shares Outstanding (Entity) over 3 years is $60.7 million, with a median of $60.7 million recorded in 2024.
• The largest YoY upside for Shares Outstanding (Entity) was 0.0% in 2025 against a maximum downside of 0.0% in 2025.
• Over 3 years, Shares Outstanding (Entity) stood at $60.7 million in 2024, then changed by 0.0% to $60.7 million in 2025, then changed by 0.0% to $60.7 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $60.7 million in Q2 2026, $60.7 million in Q4 2025, and $60.7 million in Q2 2025.